Literature DB >> 384983

Interferometric visual acuity testing in anterior segment disease.

J M Enoch, H E Bedell, H E Kaufman.   

Abstract

Preoperative and posteroperative visual acuities for Landolt ring targets and for a grating target of comparable retinal illuminance produced by two-beam interference were assessed in patients with anterior segment disease. Good preoperative interferometric acuities (6/12 or better) were found in over half of the cases in which Landolt acuities were 6/90 or worse. In general, good preoperative interferometric acuities were predictive of good postoperative Landolt acuities. However, poor interferometric acuities in patients with opacified media did not preclude good Landolt acuities postoperatively. We conclude that interferometric acuity testing can provide valuable information about potential macular resolution capacity in some cases. Both the strengths and weaknesses of interferometric acuity testing must be appreciated for successful application.

Entities:  

Mesh:

Year:  1979        PMID: 384983     DOI: 10.1001/archopht.1979.01020020364017

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Prediction of visual outcome after retinal detachment surgery using the Lotmar visometer.

Authors:  B Yazici; O Gelişken; R Avci; A Yücel
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

2.  10-Hz flash visual evoked potentials predict post-cataract extraction visual acuity.

Authors:  J V Odom; R Hobson; J T Coldren; G M Chao; G W Weinstein
Journal:  Doc Ophthalmol       Date:  1987-08       Impact factor: 2.379

3.  Preoperative prediction of postoperative visual acuity in patients with cataracts: a quantitative review.

Authors:  J V Odom; G M Chao; G W Weinstein
Journal:  Doc Ophthalmol       Date:  1988-09       Impact factor: 2.379

4.  Retinometer predicts visual outcome in Descemet membrane endothelial keratoplasty.

Authors:  Caroline Sophie Wald; Jan Darius Unterlauft; Matus Rehak; Christian Girbardt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-02-26       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.